Our findings agree with previous studies that have reported significantly decreased LHCGR expression in malignant ovarian tumors compared to benign tumors and a steady decrease in LHCGR expression from low-grade to high-grade ovarian cancer [16,18]. This evidence concerns the gene LHCGR and benign neoplasm.